AMG 076

Drug Profile

AMG 076

Alternative Names: AMG 071 programme; AMG-076; T 71

Latest Information Update: 10 Sep 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Amgen
  • Class Anorectics; Benzenesulfonates; Cyclohexanecarboxylic acids; Obesity therapies
  • Mechanism of Action MCHR1 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Obesity

Most Recent Events

  • 31 Jul 2008 Discontinued - Phase-I for Obesity in United Kingdom (PO)
  • 13 Aug 2004 Tularik has been acquired and merged into Amgen
  • 24 Feb 2004 Preclinical data have been added to the Obesity pharmacodynamics field (JP Morgan Healthcare Conference 14 January 2004)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top